MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RYTM made $51,298,000 in revenue. -$54,279,000 in net income. Net profit margin of -105.81%.

Income Overview

Revenue
$51,298,000
Net Income
-$54,279,000
Net Profit Margin
-105.81%
EPS
-$0.82
Unit: Dollar
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • US
    • Non Us

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
51,298,000 48,502,000 32,704,000 33,898,500
Cost of sales
5,499,000 5,543,000 3,648,000 3,296,500
Research and development
46,027,000 42,308,000 36,973,000 84,916,000
Selling, general, and administrative
52,425,000 45,947,000 39,087,000 36,256,000
Total costs and expenses
103,951,000 93,798,000 79,708,000 124,468,500
Loss from operations
-52,653,000 -45,296,000 -47,004,000 -90,570,000
Other income (expense), net
274,000 1,576,000 -644,000 424,500
Gain on settlement of forward contract
---0
Interest expense
4,742,000 5,817,000 5,409,000 5,379,000
Interest income
4,328,000 3,242,000 3,639,000 3,280,000
Total other (expense), net
-140,000 -999,000 -2,414,000 -1,674,500
Loss before income taxes
-52,793,000 -46,295,000 -49,418,000 -92,244,500
Provision for income taxes
111,000 337,000 80,000 105,500
Net loss
-52,904,000 -46,632,000 -49,498,000 -92,350,000
Accrued dividends on convertible preferred stock
1,375,000 1,349,000 1,322,000 669,500
Net loss attributable to common stockholders
-54,279,000 -47,981,000 -50,820,000 -93,019,500
Earnings per share, basic
-0.82 -0.75 -0.81 -1.53
Earnings per share, diluted
-0.82 -0.75 -0.81 -1.53
Weighted average number of shares outstanding, basic
66,261,055 63,684,359 63,059,165 -30,618,269
Weighted average number of shares outstanding, diluted
66,261,055 63,684,359 63,059,165 -30,618,269
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$54,279,000 Accrued dividends onconvertible preferred stock$1,375,000 Net loss-$52,904,000 Non Us$13,084,000 US$38,214,000 Provision for income taxes$111,000 Loss before incometaxes-$52,793,000 Revenue From ContractWith Customer...$51,298,000 Total other(expense), net-$140,000 Loss from operations-$52,653,000 Interest income$4,328,000 Other income(expense), net$274,000 Total revenues$51,298,000 Interest expense$4,742,000 Total costs andexpenses$103,951,000 Selling, general, andadministrative$52,425,000 Research and development$46,027,000 Cost of sales$5,499,000

RHYTHM PHARMACEUTICALS, INC. (RYTM)

RHYTHM PHARMACEUTICALS, INC. (RYTM)